Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience.

ABSTRACT:

Background

Men diagnosed with prostate cancer are at risk for competing morbidity and mortality due to cardiometabolic disease given their advanced age at diagnosis, high prevalence of pre-existing risk factors, and receipt of systemic therapy that targets the androgen receptor (AR). Expert panels have stressed the importance of cardiometabolic risk assessment in the clinic and proposed evaluating key risks using consensus paradigms. Yet, there is a gap in real-world evidence for implementation of comprehensive cardiometabolic care for men with prostate cancer.

Methods

This is a retrospective, descriptive study of patients with prostate cancer who were referred and evaluated in the Healthy Heart Program at MD Anderson Cancer Center, which was established to mitigate cardiome

SUBMITTER: Hahn AW 

PROVIDER: S-EPMC10498569 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature